Dong-Joo (Ellen) Cheon, Ph.D., is currently a postdoctoral fellow in the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center (Los Angeles, CA) under the mentorship of Dr. Sandra Orsulic. Dr. Cheon earned her B.S. and M.S. from Seoul National University (Seoul, Korea) and a Ph.D. from the University of Texas M.D. Anderson Cancer Center (Houston, TX). Her doctoral studies focused on the in-vivo functions of the ovarian cancer antigen, CA125/MUC16, in embryonic development and ovarian cancer. She joined Dr. Orsulic’s laboratory in 2009 to study the role of a collagen-remodeling gene signature in ovarian cancer metastasis and chemo-resistance. Dr. Cheon is interested in the molecular mechanisms underlying metastatic cancer progression and chemo-resistance as well as the development of novel therapeutic strategies to improve patient survival outcome. Dr. Cheon has received several awards, including the Ache-Murray Fellowship for Ovarian Cancer Research and the Schissler Foundation Fellowship in Genetics of Human Disease.